William Kelly Jones - 04 Feb 2022 Form 4 Insider Report for MAXLINEAR INC (MXL)

Role: VP of Worldwide Operations
Signature: /s/ Connie Kwong, as Attorney-in-Fact
Issuer symbol: MXL
Transactions as of: 04 Feb 2022
Net transactions value: -$123,119
Form type: 4
Filing time: 08 Feb 2022, 16:34:09 UTC
Previous filing: 05 Jan 2022
Next filing: 24 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MXL	Common Stock	Award	$0	+3,933		$0.000000	3,933	04 Feb 2022	Direct	F1
transaction	MXL	Common Stock	Tax liability	$91,671	-1,475	-38%	$62.15	2,458	04 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+880	+36%	$0.000000	3,338	04 Feb 2022	Direct	F2
transaction	MXL	Common Stock	Tax liability	$18,894	-304	-9.1%	$62.15	3,034	04 Feb 2022	Direct
transaction	MXL	Common Stock	Award	$0	+587	+19%	$0.000000	3,621	04 Feb 2022	Direct	F2
transaction	MXL	Common Stock	Tax liability	$12,554	-202	-5.6%	$62.15	3,419	04 Feb 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock issued to the Reporting Person for the 2021 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 4, 2022.
F2	Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan.

Content

Represents shares of Common Stock issued to the Reporting Person for the 2021 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 4, 2022.

Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan.